Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 44.00
  • 52 Week Low: 3.20
  • Currency: UK Pounds
  • Shares Issued: 95.37m
  • Volume: 138,126
  • Market Cap: £3.58m
  • RiskGrade: 464

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -98.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.2 n/a
Pr/Book 3.2  
Latest F'cast
Revenue -39.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FAB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 2.18 (1.50) (5.70)p n/a n/a n/a n/a 0.0%
31-Mar-20 3.90 (1.07) (3.20)p n/a n/a n/a n/a 0.0%
31-Mar-21 4.16 (1.26) (0.12)p n/a n/a n/a n/a 0.0%
31-Mar-22 4.80 (1.33) (4.60)p n/a n/a n/a n/a 0.0%
31-Mar-23 2.90 (2.86) (10.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest FAB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

FAB Market Data

Currency UK Pounds
Share Price 3.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 44.00
52 Week Low 3.20
Volume 138,126
Shares Issued 95.37m
Market Cap £3.58m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.91% below the market average44.91% below the market average44.91% below the market average44.91% below the market average44.91% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average
Price Trend
94.5% below the market average94.5% below the market average94.5% below the market average94.5% below the market average94.5% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

FAB Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
16:29 26 @ 3.80p
16:28 26 @ 3.80p
16:05 30,567 @ 3.80p
15:50 93,512 @ 3.79p
15:23 26 @ 3.80p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page